Composition
- Active ingredients
- LAMIVUDINE 300MG/300MG; TENOFOVIR
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022459.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lamivudine/Tenofovir Disoproxil Fumarate FDC Tabs
- Active substance
- lamivudine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Hetero Drugs LTD
- Status
- Tentative approval
- FDA approval
- 5 Nov 2009
- Application
- NDA022459-001